Several mechanisms can lead to the dysregulation of CENP-A in cancer. These include gene amplification, transcriptional upregulation, and post-translational modifications. Additionally, defects in the regulatory pathways that normally ensure the correct localization and amount of CENP-A at centromeres can contribute to its aberrant expression in cancer cells.
